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It was considered an interest to enhance the aqueous solubility of irbesartan. To accomplish this 
objective, the solubilization of irbesartan by cosolvency and micellization was investigated. It was found 
that all the cosolvents (ethanol, glycerol, propylene glycol) and surfactants (sodium lauryl sulfate, 
polysorbate-80) increased the solubility of irbesartan.  Sodium lauryl sulfate was observed to be the most 
effective of the solubilizing agents used. The increase in aqueous solubility of irbesartan at the maximum 
concentration studied was in the following order: sodium lauryl sulfate > polysorbate-80 > ethanol > 
propylene glycol > glycerol. 
 






is a potent, long-acting nonpeptide A II receptor 
antagonist with a high specificity for the angiotensin 
type 1 subtype (Waber 2001; Gillis 1997).  
Clinically, it is administered as tablets for 
the treatment of hypertension. Its mechanism of 
action offers irbesartan advantages in safety and 
tolerability over prior classes of drugs in the 
treatment of hypertension, diabetic neuropathy and 
heart failure (Cazaubon et al.,. 1993). Several 
reports have appeared in literature concerning the 
effects of cosolvents and surfactants on the 
solubility of slightly soluble drugs. Varia et al. (1991) 
investigated the solubilization of tipredane 
(corticosteroid) by a cosolvent system consisting of 
polyethylene glycol 400, propylene glycol and 
water. Other reports (Mbah 2006; Alkhamis et al. 
2003; Li and Zhao, 2003; Alvarez-Nunez and 
Yalkowsky, 1998) have employed cosolvency and 
micellization to increase aqueous solubility of poor 
soluble drugs. These techniques of increasing the 
solubilities of drugs with low aqueous solubilities 
have allowed their formulation into pharmaceutical 
liquid and parenteral dosage forms (Khalil et al. 
2000; Powell et al. 1998). Irbesartan presently has 
a solid dosage form (tablets) as the only 
pharmaceutical formulation. Nevertheless, the 
potential of formulating it into other dosage forms 
exists if sufficient aqueous solubility could be 
achieved through cosolvency, micellization or a 
combination of both techniques. In this context, the 
study examines the effect of ethanol, glycerol, 
propylene glycol, polysorbate-80 (tween 80) and 
sodium lauryl sulfate on the solubility of irbesartan. 
 
Materials and Methods 
 
Materials and apparatus: Irbesartan (Bristol-
Meyers Squibb, USA) and all other reagents and 
solvents were of analytical grade (BDH). 
Ultraviolet/Visible spectrophotometer (UV 2102 PC 
Unico) was used to measure the absorbance 
readings. 
 
Standard solution:  The stock solution of 
irbesartan (20 µg/ml) was prepared in methanol. 
Aliquots (2-10 µg/ml) of the standard stock solution 
were pipetted into 10 ml volumetric flask and diluted 
to volume with methanol with which a standard 
Beer’s plot was obtained. 
 
Solubility determination: The solubility was 
determined by placing excess of irbesartan (200 
mg) in flasks containing 10 ml of water, cosolvent 
and surfactant solutions respectively. The flasks 
were stoppered and shaken at 25 o C for 24 h. After 
equilibration, the supernatant was filtered and the 
absorbance taken after dilution at a maximum 
wavelength of 230 nm. The irbesartan concentration 
was calculated from the pre-constructed calibration 
curve. 
 
Results and Discussion 
 
The influence of ethanol, glycerol and propylene 
glycol on the solubility of irbesartan is shown in Fig. 
1. The graph indicates that the solvents increased 
the aqueous solubility of irbesartan and that this 
effect increases as the concentration of the 
cosolvent is increased. Considering a concentration 
level of 25 % v/v for instance, solubility of irbesartan 
was 66.0 µg/ml (1.2-fold increase) for ethyl alcohol 
compared to 60.6 µg/ml (1.1-fold increase) and 59.0 
µg/ml (1.1-fold increase) for propylene glycol and 
glycerol respectively. The observed solubilization of 
irbesartan in these solvent systems could be as a 
result of the nonpolar hydrocarbon region in the 
cosolvent, reducing the ability of the aqueous 
system to squeeze out irbesartan molecules. 
Furthermore, a decrease in the dielectric constant 
of the mixture could also explain the slight increase 
in irbesartan solubility by the added cosolvents. The 
relationship between total irbesartan solubility (Stot) 
in cosolvent system and the cosolvent 
concentration can be described by eq 1:  log Stot = 
log Sw + δ C – eq.1, where Sw is the drug solubility  
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Table 1:  Effect of cosolvents on the aqueous solubility of irbesartan 
Solubility (µg/ml) ∆G (J/mol) (25 o C) Cosolvent conc. (%v/v)    
Ethanol Glycerol Propylene 
glycol 
Ethanol Glycerol Propylene 
glycol 
0.0           55.26 55.26 55.26    
10 59.05 56.66 57.20 -162.5 -62.2 -85.8 
15 61.50 57.37 58.40 -265.5 -93.2 -137.1 
20            63.53 58.24 59.63 -345.6 -130.3 -189.1 
25 65.96 59.03 60.57 -438.9 -163.9 -227.8 
  
Table 2: Effect of surfactant solutions on the aqueous solubility of irbesartan 
Polysorbate-80 Sodium lauryl sulfate Surfactant conc.  
(% w/v) Solubility  (µg/ml) ∆G (J/mol) (25 o C ) Solubility  (µg/ml) ∆G (J/mol) (25 o C ) 
0.00                          55.26  55.26  
0.20 66.08 -443.4 169.33 -2775.3 
0.40                          75.18 -763.1 251.15 -3752.1 
1.0                           108.76 - 1678.1 501.45 -5465.6 


























in water, C is the concentration of the cosolvent and 
δ is the solubilizing factor. For a given cosolvent 
system, the solubilizing power gave a quantitative 
estimate of the ability of the stronger solvent to 
increase the solubility of irbesartan in the system. 
The free energy change (∆G) for different system 
was calculated from the thermodynamic relationship 
(Feldman and Gibaldi, 1967), ∆G   = -2.303 RT log 
Sc / Sw      - eq. 2,  where Sc / Sw is the ratio of molar 
solubility of irbesartan in cosolvent to that of water. 
The spontaneity of the process is indicated by the 
negative values of the free energy change obtained 
for different systems. The results are summarized in 
Table 1. The effect of surfactants on the solubility of 
irbesartan is given in Table 2. The results indicate 
that irbesartan solubility increased with increasing 
concentration of the surfactants. It was observed 
that sodium lauryl sulfate exhibited greater 
enhancing effect on irbesartan solubility than 
polysorbate-80. For instance, at a concentration 
level of 2 % w/v, the solubility of irbesartan was 
1077.2 µg/ml (19.5-fold increase) for sodium layryl 
sulfate and 179.0 µg/ml (3.2-fold increase) for 
polysorbate-80. The effect of sodium lauryl sulfate  
 
Fig. 1 : Plot of log aqueous
solubility (µg/ml) of irbesartan 
versus concentration of the
cosolvent. 
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Fig. 2: Plot of aqueous
solubility (µg/ml) of
irbesartan versus
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on irbesartan solubility is probably a combination of 
surfactant and pH effects. The pH effect results 
from ionized species of irbesartan (a weak acid) in 
the micelle significantly contributing to the total 
aqueous solubility. Ionized forms of drugs though 
more polar than their unionized counterpart have 
been reported to significantly contribute to the total 
drug solubility (Li et al., 1999). A plot of total 
solubility of irbesartan versus surfactant 
concentration is shown in Fig. 2. The graph shows a 
linear relationship between the drug aqueous 
solubility and the surfactant concentration for both 
surfactants. The relationship between total 
irbesartan solubility (Stot) in a micellar solution and 
surfactant concentration is given by eq. 3:  Stot = Sw 
+ kSwC – eq.3 where Sw is the drug solubility in 
water, k is the micellar partition coefficient and C is 
the concentration of the surfactant (i.e. total 
surfactant concentration minus the critical micelle 
concentration). When the critical micelle 
concentration (CMC) is small, C can be 
approximated to the total surfactant concentration. 
The effect of cosolvents and surfactants on the aqueous solubility of irbesartan 
 
431
The free energy change for the different systems 
was calculated using equation 2. The negative  
values obtained for the free energy indicate the 
spontaneity of the process 
 
Conclusion: The study indicates that cosolvency is 
not a good method of enhancing the aqueous 
solubility of irbesartan. Surfactants were found to be 
better solubilizing agents for irbesartan aqueous 
solubility than cosolvents. Sodium lauryl sulfate 
produced very significant increase in the solubility of 
irbesartan. However, the increase at the maximum 
concentration studied could not afford sufficient 
aqueous solubility of the drug to enable potential 
liquid formulation of the drug. Potential toxicity of 
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